Dermatomyositis and Respiratory disorder

Summary:

Respiratory disorder is found among people with Dermatomyositis, especially for people who are female, 60+ old.

The study analyzes which people have Respiratory disorder with Dermatomyositis. It is created by eHealthMe based on reports of 34 people who have Dermatomyositis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Dermatomyositis?

Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer) is found to be associated with 263 drugs and 415 conditions by eHealthMe. Check the latest studies of Dermatomyositis.

What is Respiratory disorder?

Respiratory disorder (respiratory disease) is found to be associated with 1,540 drugs and 1,583 conditions by eHealthMe. Check the latest studies of Respiratory disorder.



On Jul, 10, 2026

34 people who have Dermatomyositis and Respiratory Disorder are studied.

Would you have Respiratory disorder when you have Dermatomyositis?

Gender of people who have Dermatomyositis and experienced Respiratory Disorder *:

  • female: 53.33 %
  • male: 46.67 %

Age of people who have Dermatomyositis and experienced Respiratory Disorder *:

  • 0-1: 0.0 %
  • 2-9: 24 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20 %
  • 50-59: 8 %
  • 60+: 48 %

Common co-existing conditions for these people *:

  1. Interstitial Lung Disease: 16 people, 47.06%
  2. Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 3 people, 8.82%
  3. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 1 person, 2.94%
  4. Pneumonia Cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses): 1 person, 2.94%
  5. Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 2.94%
  6. Cytomegalovirus Infection: 1 person, 2.94%
  7. Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 2.94%

Common drugs taken by these people *:

  1. Prednisolone: 9 people, 26.47%
  2. Cyclosporine: 9 people, 26.47%
  3. Tacrolimus: 6 people, 17.65%
  4. Ciclosporin: 5 people, 14.71%
  5. Methylprednisolone: 5 people, 14.71%
  6. Neoral: 4 people, 11.76%
  7. Sulfamethoxazole And Trimethoprim: 3 people, 8.82%
  8. Methylprednisolone Sodium Succinate: 2 people, 5.88%
  9. Remicade: 2 people, 5.88%
  10. Prograf: 2 people, 5.88%

Common symptoms for these people *:

  1. Interstitial Lung Disease: 10 people, 29.41%
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 11.76%
  3. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 4 people, 11.76%
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 4 people, 11.76%
  5. Fatigue (feeling of tiredness): 4 people, 11.76%
  6. Endocarditis Noninfective (an inflammation of the inner layer of the heart noninfective): 3 people, 8.82%
  7. Diffuse Alveolar Damage (common manifestation of drug-induced lung injury): 3 people, 8.82%
  8. Splenic Infarction (tissue damage of spleen): 3 people, 8.82%
  9. Aortic Embolus (obstruction of aortic artery): 3 people, 8.82%
  10. Pulmonary Bulla (air pockets within the lung tissue): 3 people, 8.82%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Respiratory disorder?

- Check whether Respiratory disorder is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Respiratory disorder:

All the conditions that are associated with Respiratory disorder:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Respiratory disorder and Dermatomyositis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: